President Cyril Ramaphosa has launched South Africa’s rollout of Lenacapavir, a twice-yearly HIV prevention injection aimed at reducing new infections and strengthening the country’s long-term HIV response strategy.

Limited supplies threaten potential positive effect of HIV prevention drug lenacapavir

Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa

The Presidency says Lenacapavir, a twice-yearly HIV prevention injection, will expand biomedical tools in South Africa’s fight against new infections and strengthen long-term…

President Cyril Ramaphosa is on Friday launching the rollout of Lenacapavir, a new injectable prevention for HIV/Aids.

President Cyril Ramaphosa has launched South Africa’s rollout of Lenacapavir, a twice-yearly HIV prevention injection aimed at reducing new infections and strengthening the…

A new twice-yearly HIV prevention injection could transform South Africa's fight against the epidemic — but U.S. aid cuts and limited doses threaten to slow its impact.

La OMS calificó la decisión de extender su uso como histórica y considera que podría redefinir la respuesta global a la epidemia.

South Africa officially launched the national rollout of Lenacapavir, a groundbreaking, twice-yearly injectable drug for HIV prevention